This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Drugs

Walgreen, Economic Data: What to Watch on Wall Street Dec. 23

  • Tickers in this article:
  • WAG

On Tuesday, December 23th, Wall Street will look to Walgreen Co. as it reports fiscal first quarter results before the opening bell.

12/22/14 - 08:00 PM EST

Gilead Slips After Abbvie Lowers Price of Hepatitis-C Drug

Gilead Pharmaceuticals (GILD) plunged over 14% on Monday, making it TheStreet's Move of the Day.

12/22/14 - 05:32 PM EST

Try Jim Cramer's Action Alerts PLUS
Express Scripts Turns to AbbVie in Huge Hepatitis C Deal

Express Scripts Turns to AbbVie in Huge Hepatitis C Deal

The nation's largest pharmacy benefits manager is throwing its weight into a fight over the high cost of treating hepatitis C, saying it will cover a drug from AbbVie.

12/22/14 - 01:57 PM EST

Walgreen Lags CVS Health, but Both Are Technically Overbought

Walgreen Lags CVS Health, but Both Are Technically Overbought

  • Tickers in this article:
  • CVS
  • WAG

CVS Health expanded its Minute Clinic and quit selling cigarettes, while Walgreen still sells smokes and will move to the Nasdaq after completing a merger. Here's how to trade them.

12/22/14 - 01:34 PM EST

American Apparel Spikes On Confirming It's Considering Buyout Offer

Stocks were making an effort to extend last week's big rally but struggled to move much higher in midday trading Monday.

12/22/14 - 11:48 AM EST

Achillion Pharma Takeout Less Likely Following Subpar Hep C Drug Results

Achillion Pharma Takeout Less Likely Following Subpar Hep C Drug Results

These Achillion results aren't great because the speed at which drugs kill the hepatitis C virus matters. Slower-acting drugs leave patients vulnerable to viral rebound or relapse.

12/22/14 - 11:36 AM EST

AbbVie's Exclusive Hepatitis C Deal With Express Scripts: What Wall Street's Saying

AbbVie's Exclusive Hepatitis C Deal With Express Scripts: What Wall Street's Saying

AbbVie strikes an exclusive deal with Express Scripts to exclusively distribute AbbVie's hepatitis C therapy. Here's what analysts said.

12/22/14 - 11:20 AM EST

Walgreen To Leave NYSE for Nasdaq After Merger With Alliance Boots

Stocks eyed further gains at Monday's opening bell on this shortened trading week.

12/22/14 - 09:55 AM EST

J.P. Morgan's 6 Top Biotech and Pharmaceuticals Stocks to Buy in 2015

J.P. Morgan's 6 Top Biotech and Pharmaceuticals Stocks to Buy in 2015

Which biotech and pharmaceuticals stocks should investors buy in 2015? JPMorgan named six companies with the best investment cases as part of its top U.S. stocks picks for 2015.

12/22/14 - 08:23 AM EST

Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market

Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market

The power to control drug prices in the U.S. now has shifted firmly to cost-cutting insurance carriers and pharmacy benefit managers and away from biotech and drug companies.

12/22/14 - 06:14 AM EST

Holiday Schedule, Walgreen: What to Watch for the Week Ahead

  • Tickers in this article:
  • WAG

For the week of December 22nd 2014, Wall Street will be on a holiday schedule.

12/21/14 - 12:00 PM EST

Abbvie's Hep C Regimen Approved, Marketing Battle With Gilead Up Next

Abbvie's Hep C Regimen Approved, Marketing Battle With Gilead Up Next

U.S. regulators approved a new hepatitis C therapy from Abbvie, heralding a new era of market competition with Gilead Sciences.

12/19/14 - 04:16 PM EST

Cramer: If Walgreen Sells Off on Earnings, That's a Chance to Buy

Walgreen reports its latest quarterly results next week and Jim Cramer believes it will be a key item to watch.

12/19/14 - 12:06 PM EST

Stephanie Link's Top 3 Stocks Picks in the Healthcare Space for 2015

Stephanie Link picks baskets of stocks that diversified within the sector itself and says that will be applied to her 2015 Healthcare picks.

12/19/14 - 11:00 AM EST

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Markets

DOW 17,959.44 +154.64 0.87%
S&P 500 2,078.54 +7.89 0.38%
NASDAQ 4,781.4240 +16.0440 0.34%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs